Table 2.

Cytoplasmic Free Calcium [Ca2+]c Levels in Resting and Stimulated Neutrophils

C Day 0 P Day 0 C Day 4 P Day 4
fMLP (baseline) 0.03 ± 0.00  0.06 ± 0.01  0.04 ± 0.01 0.07 ± 0.01  
fMLP (peak)  0.75 ± 0.06 0.99 ± 0.07  0.99 ± 0.17 2.35 ± 0.24*, 
PAF (baseline) 0.07 ± 0.03  0.06 ± 0.00  0.04 ± 0.00 0.11 ± 0.03  
PAF (peak)  1.43 ± 0.32 1.55 ± 0.20  1.80 ± 0.36  3.03 ± 0.65*, 
C Day 0 P Day 0 C Day 4 P Day 4
fMLP (baseline) 0.03 ± 0.00  0.06 ± 0.01  0.04 ± 0.01 0.07 ± 0.01  
fMLP (peak)  0.75 ± 0.06 0.99 ± 0.07  0.99 ± 0.17 2.35 ± 0.24*, 
PAF (baseline) 0.07 ± 0.03  0.06 ± 0.00  0.04 ± 0.00 0.11 ± 0.03  
PAF (peak)  1.43 ± 0.32 1.55 ± 0.20  1.80 ± 0.36  3.03 ± 0.65*, 

Neutrophil [Ca2+] mobilization was assayed as described in Materials and Methods. There was a slight increase in baseline calcium in the PAF stimulus experiments. On day 4 of G-CSF administration, there was significant enhancement of both PAF and fMLP-stimulated peak mobilization compared with treated day 0 levels (P ≤ .0005) and compared with control day 4 levels (P ≤ .003). Results represent μmol/L concentration of cytosolic calcium and are expressed as mean ± SEM, n = 6 (matched pairs).

*

P ≤ .0005.

P ≤ .003.

or Create an Account

Close Modal
Close Modal